Xylem Inc (NYSE:XYL) – Research analysts at Oppenheimer issued their Q1 2018 earnings per share estimates for shares of Xylem in a research report issued on Friday. Oppenheimer analyst J. Giannakouros anticipates that the industrial products company will post earnings per share of $0.50 for the quarter. Oppenheimer has a “Outperform” rating and a $82.00 price objective on the stock. Oppenheimer also issued estimates for Xylem’s Q2 2018 earnings at $0.71 EPS, Q3 2018 earnings at $0.79 EPS, Q4 2018 earnings at $0.90 EPS, FY2018 earnings at $2.90 EPS and FY2019 earnings at $3.40 EPS.

Xylem (NYSE:XYL) last announced its quarterly earnings results on Thursday, February 1st. The industrial products company reported $0.76 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.76. Xylem had a return on equity of 17.95% and a net margin of 7.03%. The company had revenue of $1.28 billion during the quarter, compared to analysts’ expectations of $1.27 billion. During the same quarter in the previous year, the firm earned $0.66 earnings per share. The business’s quarterly revenue was up 16.6% compared to the same quarter last year.

A number of other analysts have also recently weighed in on the company. BMO Capital Markets reaffirmed a “buy” rating and issued a $86.00 price target on shares of Xylem in a research report on Friday, February 2nd. Seaport Global Securities reaffirmed a “buy” rating and issued a $83.00 price target on shares of Xylem in a research report on Friday, February 2nd. Canaccord Genuity reaffirmed a “hold” rating and issued a $75.00 price target on shares of Xylem in a research report on Sunday, January 28th. Zacks Investment Research cut Xylem from a “buy” rating to a “hold” rating in a research report on Monday, January 22nd. Finally, Royal Bank of Canada reissued a “buy” rating and set a $80.00 price objective on shares of Xylem in a research report on Thursday, January 4th. Six research analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and a consensus target price of $70.00.

Shares of Xylem (NYSE:XYL) opened at $71.33 on Monday. Xylem has a 12-month low of $46.78 and a 12-month high of $76.81. The firm has a market capitalization of $13,588.54, a PE ratio of 38.77, a price-to-earnings-growth ratio of 1.74 and a beta of 1.20. The company has a debt-to-equity ratio of 0.87, a current ratio of 1.88 and a quick ratio of 1.41.

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, March 15th. Investors of record on Thursday, February 15th will be given a dividend of $0.21 per share. This represents a $0.84 annualized dividend and a dividend yield of 1.18%. The ex-dividend date is Wednesday, February 14th. This is a boost from Xylem’s previous quarterly dividend of $0.18. Xylem’s payout ratio is currently 39.13%.

In related news, insider Tomas Brannemo sold 2,260 shares of the business’s stock in a transaction dated Tuesday, December 19th. The stock was sold at an average price of $67.75, for a total transaction of $153,115.00. Following the transaction, the insider now directly owns 10,975 shares in the company, valued at $743,556.25. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Steven R. Loranger sold 17,139 shares of the business’s stock in a transaction dated Wednesday, December 20th. The shares were sold at an average price of $68.10, for a total value of $1,167,165.90. Following the transaction, the director now owns 26,150 shares in the company, valued at $1,780,815. The disclosure for this sale can be found here. Insiders have sold a total of 67,507 shares of company stock valued at $4,596,445 in the last three months. 0.75% of the stock is owned by insiders.

Institutional investors and hedge funds have recently modified their holdings of the stock. Invictus RG bought a new position in Xylem during the third quarter valued at about $104,000. Hanson & Doremus Investment Management bought a new stake in shares of Xylem in the 4th quarter valued at approximately $126,000. FNY Partners Fund LP grew its stake in shares of Xylem by 2,700.0% in the 3rd quarter. FNY Partners Fund LP now owns 2,800 shares of the industrial products company’s stock valued at $175,000 after purchasing an additional 2,700 shares during the period. UMB Bank N A MO bought a new stake in shares of Xylem in the 4th quarter valued at approximately $205,000. Finally, BTIM Corp. bought a new stake in shares of Xylem in the 4th quarter valued at approximately $206,000. Hedge funds and other institutional investors own 85.49% of the company’s stock.

TRADEMARK VIOLATION WARNING: This article was originally published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this article on another website, it was stolen and republished in violation of United States & international copyright law. The legal version of this article can be read at https://www.thecerbatgem.com/2018/02/07/brokers-offer-predictions-for-xylem-incs-q1-2018-earnings-xyl.html.

About Xylem

Xylem Inc is a water technology company. The Company designs, manufactures and services engineered solutions across a range of critical applications. It is an equipment and service provider for water and wastewater applications with a portfolio of products and services addressing the cycle of water, from collection, distribution and use to the return of water to the environment.

Earnings History and Estimates for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.